Intrexon Corp.

Oxitec’s Gene Modified Mosquitoes Appear As Lone Mean To Fight Against Spread of Zika Virus

WHO on Thursday has warned for probable spread of Zika virus across the North and Central American countries. Ahead of rising concerns for Zika spreading, drug makers and scientists have commented that manufacturing of an appropriate vaccine may even require a decade. These warnings has opened a huge business potential for Oxitec, an Intrexon subsidiary. Oxitec’s gene modified mosquitoes are capable of ensuring security against Zika for large populations.

Read Full Article

Maryland received US$320 million in venture capital funds in the second quarter

A PricewaterhouseCoopers report revealed that venture capitalist invested around US$320 million into Maryland last quarter.

Read Full Article

Biotech, Intrexon Corp, files for IPO

A biotech company wants to raise US$125 million through its IPO.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics